Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
Stephanie Herman(Uppsala University), Kim Kultima(Uppsala University), Ola Spjuth(Uppsala University), Payam Emami Khoonsari(Stockholm University), Henrik Zetterberg(University of Wisconsin–Madison), Joachim Burman(Uppsala University), Julia Steinmetz(TU Dortmund University), Anders Larsson(Uppsala University), Torbjörn Åkerfeldt(Uppsala University), Per‐Johan Jakobsson(Karolinska University Hospital), Andreas Tolf(Uppsala University)
Cited by 67
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589